Evidence map›Paper›PMID 36033706›Full record

ArticleACS omega2022

Aflatoxin B1 Acts as an Effective Energy Donor to Enhance Fluorescence of Yellow Emissive Carbon Dots.

Özge Ergüder, Sultan Şahin Keskin, Ilgın Nar, Levent Trabzon, Caner Ünlü

Abstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Özge ErgüderDepartment of Nanoscience and Nanoengineering, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.
Sultan Şahin KeskinDepartment of Nanoscience and Nanoengineering, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.ORCID https://orcid.org/0000-0001-6606-5622
Ilgın NarIstanbul Technical University Nanotechnology Research and Application Center (ITUNano), 34469 Istanbul, Turkey.ORCID https://orcid.org/0000-0003-2300-3071
Levent TrabzonMEMS Research Center, Istanbul Technical University, 34469 Istanbul, Turkey.
Caner ÜnlüDepartment of Nanoscience and Nanoengineering, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.ORCID https://orcid.org/0000-0002-0612-3111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon dots (CDs) are versatile fluorescent nanocrystals with unique optical and structural properties and are commonly used in biosensing, bioimaging, and biomolecule tagging studies. However, fluorescence of CDs is brightest in the wavelength range of 430-530 nm, which overlaps with the autofluorescence range of many eukaryotic cells and makes CDs impractical for in vivo and in vitro imaging studies. Thus, the design of yellow-red emissive CDs with high quantum yield is of importance. In this study, the quantum yield of traditional yellow emissive CDs was enhanced by two different methods: (1) the surface of traditional yellow emissive CDs passivated with a biomolecule, urea, through easy, rapid, inexpensive microwave assisted synthesis methods and (2) a fluorescent biomolecule, aflatoxin B1, used as an energy donor for yellow emissive CDs. In the first method, the quantum yield of the CDs was enhanced to 51%. In the second method, an efficient energy transfer (above 40%) from aflatoxin B1 to the CDs was observed. Our study showed that highly luminescent yellow emissive CDs can be synthesized by simple, rapid microwave assisted synthesis methods, and these CDs are potential candidates to sense aflatoxin B1. Furthermore, our results indicated that Aflatoxin B1 can be considered as an emission booster for CDs.

Identifiers

PMID36033706
PMCPMC9404464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.